REG - Adv Medical Solutns. - Form 8 (OPD)
Today 16:45
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260604:nRSD0920Ha&default-theme=true
RNS Number : 0920H Advanced Medical Solutions Grp PLC 04 June 2026
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Advanced Medical Solutions Group PLC
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Advanced Medical Solutions Group PLC
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? Offeree
(e) Date position held: 3 June 2026
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary Shares of 5 pence each
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil Nil Nil Nil
(2) Cash-settled derivatives: Nil Nil Nil Nil
(3) Stock-settled derivatives (including options) and agreements to Nil Nil Nil Nil
purchase/sell:
Nil Nil Nil Nil
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: None
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
Interests of directors
Advanced Medical Solutions Group PLC ordinary shares held by directors of
Advanced Medical Solutions Group PLC:
Name Number of AMS Shares Percentage of AMS existing issued ordinary share capital
Christopher Meredith 1,913,213(1) 0.87%
Edward Johnson 196,588(2) 0.089%
Grahame Cook 48,864 0.022%
Susan Searle 10,000(3) 0.0045%
(1) Includes 1,389,815 shares held by Christopher Meredith's close relatives.
(2) Includes 28,084 shares held by Edward Johnson's close relative.
(3) Includes 5,000 shares held by Susan Searle's close relative.
Interests held as options or awards by directors of Advanced Medical Solutions
Group PLC in ordinary shares of Advanced Medical Solutions Group PLC:
(A) Christopher Meredith
(i) Employee Share Purchase Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
28,060 12/05/2022 12/05/2022 - Nil
13,143 17/05/2023 17/05/2023 - Nil
26,286 17/05/2023 17/05/2026 - Nil
25,288 11/11/2024 11/11/2024 - Nil
50,576 11/11/2024 11/11/2027 - Nil
32,168 13/05/2025 13/05/2025 - Nil
64,336 13/05/2025 13/05/2028 - Nil
(ii) Share Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
586 30/04/2018 30/04/2018 - Nil
586 30/04/2018 30/04/2021 - Nil
545 29/04/2019 29/04/2019 - Nil
545 29/04/2019 29/04/2022 - Nil
734 05/05/2020 05/05/2020 - Nil
734 05/05/2020 05/05/2023 - Nil
661 11/05/2021 11/05/2021 - Nil
661 11/05/2021 11/05/2024 - Nil
665 12/05/2022 12/05/2022 - Nil
665 12/05/2022 12/05/2025 - Nil
716 17/05/2023 17/05/2023 - Nil
1,432 17/05/2023 17/05/2026 - Nil
801 11/11/2024 11/11/2024 - Nil
1,602 11/11/2024 11/11/2027 - Nil
923 13/05/2025 13/05/2025 - Nil
1,846 13/05/2025 13/05/2028 - Nil
(iii) Long Term Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
150,199 14/04/2022 14/04/2025 14/04/2032 Nil
216,320 14/04/2023 14/04/2026 14/04/2033 Nil
411,478 23/04/2024 23/04/2027 23/04/2034 Nil
438,194 30/04/2025 30/04/2028 30/04/2035 Nil
(iv) Deferred Bonus Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
6,219 14/04/2022 14/04/2025 14/04/2032 Nil
31,138 14/04/2023 14/04/2026 14/04/2033 Nil
(B) Edward Johnson
(i) Employee Share Purchase Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
8,201 03/05/2016 03/05/2016 - Nil
6,476 02/05/2017 02/05/2017 - Nil
6,259 30/04/2018 30/04/2018 - Nil
3,302 29/04/2019 29/04/2019 - Nil
9,830 05/05/2020 05/05/2020 - Nil
8,945 11/05/2021 11/05/2021 - Nil
19,252 17/05/2023 17/05/2023 - Nil
38,504 17/05/2023 17/05/2026 - Nil
16,428 11/11/2024 11/11/2024 - Nil
32,856 11/11/2024 11/11/2027 - Nil
20,669 13/05/2025 13/05/2025 - Nil
41,338 13/05/2025 13/05/2028 - Nil
(ii) Share Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
1,428 30/04/2014 30/04/2014 - Nil
1,428 30/04/2014 30/04/2017 - Nil
1,271 29/04/2015 29/04/2015 - Nil
1,271 29/04/2015 29/04/2018 - Nil
983 03/05/2016 03/05/2016 - Nil
983 03/05/2016 03/05/2019 - Nil
681 02/05/2017 02/05/2017 - Nil
681 02/05/2017 02/05/2020 - Nil
586 30/04/2018 30/04/2018 - Nil
586 30/04/2018 30/04/2021 - Nil
545 29/04/2019 29/04/2019 - Nil
545 29/04/2019 29/04/2022 - Nil
734 05/05/2020 05/05/2020 - Nil
734 05/05/2020 05/05/2023 - Nil
661 11/05/2021 11/05/2021 - Nil
661 11/05/2021 11/05/2024 - Nil
665 12/05/2022 12/05/2022 - Nil
665 12/05/2022 12/05/2025 - Nil
716 17/05/2023 17/05/2023 - Nil
1,432 17/05/2023 17/05/2026 - Nil
801 11/11/2024 11/11/2024 - Nil
1,602 11/11/2024 11/11/2027 - Nil
923 13/05/2025 13/05/2025 - Nil
1,846 13/05/2025 13/05/2028 - Nil
(iii) Long Term Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
56,324 14/04/2022 14/04/2025 14/04/2032 Nil
89,285 14/04/2023 14/04/2026 14/04/2033 Nil
169,837 23/04/2024 23/04/2027 23/04/2034 Nil
180,864 30/04/2025 30/04/2028 30/04/2035 Nil
(iv) Deferred Bonus Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
13,528 14/04/2023 14/04/2026 14/04/2033 Nil
(1) Includes 1,389,815 shares held by Christopher Meredith's close relatives.
(2) Includes 28,084 shares held by Edward Johnson's close relative.
(3) Includes 5,000 shares held by Susan Searle's close relative.
Interests held as options or awards by directors of Advanced Medical Solutions
Group PLC in ordinary shares of Advanced Medical Solutions Group PLC:
(A) Christopher Meredith
(i) Employee Share Purchase Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
28,060 12/05/2022 12/05/2022 - Nil
13,143 17/05/2023 17/05/2023 - Nil
26,286 17/05/2023 17/05/2026 - Nil
25,288 11/11/2024 11/11/2024 - Nil
50,576 11/11/2024 11/11/2027 - Nil
32,168 13/05/2025 13/05/2025 - Nil
64,336 13/05/2025 13/05/2028 - Nil
(ii) Share Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
586 30/04/2018 30/04/2018 - Nil
586 30/04/2018 30/04/2021 - Nil
545 29/04/2019 29/04/2019 - Nil
545 29/04/2019 29/04/2022 - Nil
734 05/05/2020 05/05/2020 - Nil
734 05/05/2020 05/05/2023 - Nil
661 11/05/2021 11/05/2021 - Nil
661 11/05/2021 11/05/2024 - Nil
665 12/05/2022 12/05/2022 - Nil
665 12/05/2022 12/05/2025 - Nil
716 17/05/2023 17/05/2023 - Nil
1,432 17/05/2023 17/05/2026 - Nil
801 11/11/2024 11/11/2024 - Nil
1,602 11/11/2024 11/11/2027 - Nil
923 13/05/2025 13/05/2025 - Nil
1,846 13/05/2025 13/05/2028 - Nil
(iii) Long Term Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
150,199 14/04/2022 14/04/2025 14/04/2032 Nil
216,320 14/04/2023 14/04/2026 14/04/2033 Nil
411,478 23/04/2024 23/04/2027 23/04/2034 Nil
438,194 30/04/2025 30/04/2028 30/04/2035 Nil
(iv) Deferred Bonus Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
6,219 14/04/2022 14/04/2025 14/04/2032 Nil
31,138 14/04/2023 14/04/2026 14/04/2033 Nil
(B) Edward Johnson
(i) Employee Share Purchase Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
8,201 03/05/2016 03/05/2016 - Nil
6,476 02/05/2017 02/05/2017 - Nil
6,259 30/04/2018 30/04/2018 - Nil
3,302 29/04/2019 29/04/2019 - Nil
9,830 05/05/2020 05/05/2020 - Nil
8,945 11/05/2021 11/05/2021 - Nil
19,252 17/05/2023 17/05/2023 - Nil
38,504 17/05/2023 17/05/2026 - Nil
16,428 11/11/2024 11/11/2024 - Nil
32,856 11/11/2024 11/11/2027 - Nil
20,669 13/05/2025 13/05/2025 - Nil
41,338 13/05/2025 13/05/2028 - Nil
(ii) Share Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
1,428 30/04/2014 30/04/2014 - Nil
1,428 30/04/2014 30/04/2017 - Nil
1,271 29/04/2015 29/04/2015 - Nil
1,271 29/04/2015 29/04/2018 - Nil
983 03/05/2016 03/05/2016 - Nil
983 03/05/2016 03/05/2019 - Nil
681 02/05/2017 02/05/2017 - Nil
681 02/05/2017 02/05/2020 - Nil
586 30/04/2018 30/04/2018 - Nil
586 30/04/2018 30/04/2021 - Nil
545 29/04/2019 29/04/2019 - Nil
545 29/04/2019 29/04/2022 - Nil
734 05/05/2020 05/05/2020 - Nil
734 05/05/2020 05/05/2023 - Nil
661 11/05/2021 11/05/2021 - Nil
661 11/05/2021 11/05/2024 - Nil
665 12/05/2022 12/05/2022 - Nil
665 12/05/2022 12/05/2025 - Nil
716 17/05/2023 17/05/2023 - Nil
1,432 17/05/2023 17/05/2026 - Nil
801 11/11/2024 11/11/2024 - Nil
1,602 11/11/2024 11/11/2027 - Nil
923 13/05/2025 13/05/2025 - Nil
1,846 13/05/2025 13/05/2028 - Nil
(iii) Long Term Incentive Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
56,324 14/04/2022 14/04/2025 14/04/2032 Nil
89,285 14/04/2023 14/04/2026 14/04/2033 Nil
169,837 23/04/2024 23/04/2027 23/04/2034 Nil
180,864 30/04/2025 30/04/2028 30/04/2035 Nil
(iv) Deferred Bonus Plan
No. of Advanced Medical Solutions Group Plc ordinary shares of which options Date of grant Vesting date Expiry date Exercise price (£)
granted / subject to award
13,528 14/04/2023 14/04/2026 14/04/2033 Nil
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) No
Supplemental Form 8 (SBL) No
Date of disclosure: 4 June 2026
Contact name: Owen Bromley, Company Secretary
Telephone number: 01606 545514
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEEAKQBBPBKDFAK
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Advanced Medical Solutions
See all newsREG - Adv Medical Solutns. - Form 8 (OPD)
AnnouncementREG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
AnnouncementREG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc
AnnouncementREG - Verition Fund Mgmt Adv Medical Solutns. - Form 8.3 - ADVANCED MEDICAL SOLUTIONS GROUP PLC
AnnouncementREG - Goldman Sachs (EPT) Adv Medical Solutns. - Form 8.5 (EPT/NON-RI) - ADVANCED MEDICAL SOLUTIONS
Announcement